98%
921
2 minutes
20
Parkinson's disease is brought on by a disturbance in the functions of the brain cells that are responsible for the production of dopamine, which is a chemical that enables brain cells to interact with one another. The cells in the brain responsible for the production of dopamine are the ones in charge of the regulation, adaptability, and fluency of movements. When sixty to eighty percent of these cells are gone, there is a lack of sufficient dopamine production, which makes Parkinson's motor symptoms manifest. In this study, a robust diagnosis of Parkinson's disease is presented in terms of optimized machine-learning models. Specifically, a novel hybrid optimization algorithm is proposed for both feature selection and optimization of the parameters of a neural network to boost the classification of Parkinson's disease. The proposed optimization algorithm is a hybrid of the greylag goose and particle swarm optimization algorithm, denoted by GGPSO. This approach is applied to classifying Parinson's disease from speech signals. The proposed feature selection method is compared to recent methods, showing a promising performance with superior results. In addition, the performance of the proposed optimization algorithm is compared to other optimization algorithms to prove its superiority and effectiveness in optimizing the parameters of the neural network. The overall classification accuracy using the proposed approach is 99.4%, which outperforms the other competing methods. On the other hand, statistical tests have been performed to show the stability and statistical difference of the proposed method. The results of these study confirmed the achieved outcomes and showed robust performance of the proposed methodology in classifying Parkinson's disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.compbiomed.2025.110924 | DOI Listing |
Neurology
October 2025
Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.
Background And Objectives: Years before diagnosis of Parkinson disease (PD), dementia with Lewy bodies (DLB), or multiple system atrophy (MSA), mild prodromal manifestations can be detected. Longitudinal follow-up of people with prodromal synucleinopathy, particularly idiopathic/isolated REM sleep behavior disorder (iRBD), enables in-depth clinical phenotyping of early disease, which could facilitate stratification for clinical trials, provide the definition of appropriate end points, or predict phenoconversion more precisely. The aim of this study was to update and expand on previous studies assessing clinical evolution from iRBD to clinically diagnosed disease, up to 14 years before diagnosis.
View Article and Find Full Text PDFJ Xray Sci Technol
September 2025
Center for Medical Artificial Intelligence, Shandong University of Traditional Chinese Medicine, Qingdao, China.
Parkinson's disease (PD) is a challenging neurodegenerative condition often prone to diagnostic errors, where early and accurate diagnosis is critical for effective clinical management. However, existing diagnostic methods often fail to fully exploit multimodal data or systematically incorporate expert domain knowledge. To address these limitations, we propose MKD-Net, a multimodal and knowledge-driven diagnostic framework that integrates imaging and non-imaging clinical data with structured expert insights to enhance diagnostic performance.
View Article and Find Full Text PDFArch Pharm Res
September 2025
College of Pharmacy, Hanyang University, Ansan, 15588, Republic of Korea.
c-Jun N-terminal kinases (JNKs), a subfamily of mitogen-activated protein kinases (MAPKs), are key mediators of cellular responses to environmental stress, inflammation, and apoptotic signals. The three isoforms-JNK1, JNK2, and JNK3 exhibit both overlapping and isoform-specific functions. While JNK1 and JNK2 are broadly expressed across tissues and regulate immune signaling, cell proliferation, and apoptosis, JNK3 expression is largely restricted to the brain, heart, and testis, where it plays a crucial role in neuronal function and survival.
View Article and Find Full Text PDFClin Auton Res
September 2025
Department of Neurology, University of Utah, Salt Lake City, UT, USA.
J Neurol
September 2025
Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Background: The "Systematic Screening of Handwriting Difficulties in Parkinson's Disease" (SOS) test is the only tool specifically designed to evaluate handwriting in people with Parkinson's Disease (pwPD). It is language specific.
Objective: To assess the construct validity, intrarater and interrater reliability of the Italian version of the SOS test.